Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ursula Becker

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Wilhelm Roux' Archiv Fur Entwicklungsmechanik Der Organismen|March 30, 2017
Ursula Becker
Wilhelm Roux' Archiv Fur Entwicklungsmechanik Der Organismen|March 30, 2017
Ursula Becker
Pilot and Feasibility Studies|March 5, 2020
Application of Marte Meo® counselling with people with behavioural variant frontotemporal dementia and their primary carers (AMEO-FTD) - a non-randomized mixed-method feasibility studyMartin Berwig, Claudia Dinand, Ursula Becker, et al.
Journal of Managed Care & Specialty Pharmacy|March 3, 2022
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory settingNick Jovanoski, Andreas Kuznik, Ursula Becker, et al.
Clinical Therapeutics|March 14, 2016
Cost-effectiveness of First-line Chronic Lymphocytic Leukemia Treatments When Full-dose Fludarabine Is UnsuitableErkki Soini, Anne Hautala, Eira Poikonen, et al.
Applied Health Economics and Health Policy|March 26, 2017
Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based TherapyAna Teresa Paquete, Luís Silva Miguel, Ursula Becker, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2008
Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosisMiroslaw Kornek, Esther Raskopf, Rene Tolba, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based TherapyUrsula Becker, Andrew H Briggs, Santiago G Moreno, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2007
Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1Angela M Meyer zum Gottesberge, Oliver Gross, Ursula Becker-Lendzian, et al.
Molecular Medicine (Cambridge, Mass.)|April 9, 2008
1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosisMiroslaw Kornek, Veronika Lukacs-Kornek, Andreas Limmer, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Wilhelm Roux' Archiv Fur Entwicklungsmechanik Der Organismen|March 30, 2017
Ursula Becker
Wilhelm Roux' Archiv Fur Entwicklungsmechanik Der Organismen|March 30, 2017
Ursula Becker
Pilot and Feasibility Studies|March 5, 2020
Application of Marte Meo® counselling with people with behavioural variant frontotemporal dementia and their primary carers (AMEO-FTD) - a non-randomized mixed-method feasibility studyMartin Berwig, Claudia Dinand, Ursula Becker, et al.
Journal of Managed Care & Specialty Pharmacy|March 3, 2022
Cost-effectiveness of casirivimab/imdevimab in patients with COVID-19 in the ambulatory settingNick Jovanoski, Andreas Kuznik, Ursula Becker, et al.
Clinical Therapeutics|March 14, 2016
Cost-effectiveness of First-line Chronic Lymphocytic Leukemia Treatments When Full-dose Fludarabine Is UnsuitableErkki Soini, Anne Hautala, Eira Poikonen, et al.
Applied Health Economics and Health Policy|March 26, 2017
Cost-Effectiveness Analysis of Obinutuzumab for Previously Untreated Chronic Lymphocytic Leukaemia in Portuguese Patients who are Unsuitable for Full-Dose Fludarabine-Based TherapyAna Teresa Paquete, Luís Silva Miguel, Ursula Becker, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 15, 2008
Accelerated orthotopic hepatocellular carcinomas growth is linked to increased expression of pro-angiogenic and prometastatic factors in murine liver fibrosisMiroslaw Kornek, Esther Raskopf, Rene Tolba, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 22, 2016
Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based TherapyUrsula Becker, Andrew H Briggs, Santiago G Moreno, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 21, 2007
Inner ear defects and hearing loss in mice lacking the collagen receptor DDR1Angela M Meyer zum Gottesberge, Oliver Gross, Ursula Becker-Lendzian, et al.
Molecular Medicine (Cambridge, Mass.)|April 9, 2008
1,2-dioleoyl-3-trimethylammonium-propane (DOTAP)-formulated, immune-stimulatory vascular endothelial growth factor a small interfering RNA (siRNA) increases antitumoral efficacy in murine orthotopic hepatocellular carcinoma with liver fibrosisMiroslaw Kornek, Veronika Lukacs-Kornek, Andreas Limmer, et al.
Pageof 3